Scientists have made great progress in harnessing the body's own immune cells to treat so-called liquid tumors, cancers of the blood and lymphatic system. Yet these powerful cell therapies have been ...

Cancer can become very difficult to treat when it returns or stops responding to standard therapies. This is especially true ...

Natural killer cells act as the immune system’s rapid-response team, but the stress of anxiety and insomnia may be quietly thinning their ranks. A study of young women in Saudi Arabia found that both ...

The composition of donor cord blood may play a critical role in the success of chimeric antigen receptor (CAR) natural killer (NK) cell therapies. A small population of immature NK cells present in ...

Newswise — Cell-based immunotherapies have transformed cancer treatment, yet their widespread use remains constrained by safety risks, manufacturing complexity, and limited effectiveness against solid ...

Newswise — For decades, natural killer (NK) cells have been classified into two main groups based on surface markers: one specialized for cytokine production and the other for direct killing. But this ...

Collaboration will generate human iPSC-derived brain cell models to investigate the effects of Evinco's NK-EV platform on neuroinflammation Melbourne ...

A research team led by Prof. Wang Yi and Wei Haiming from the University of Science and Technology of China (USTC), in collaboration with Prof. Ding Chen's team from Human Phenome Institute at Fudan ...

Evinco Therapeutics and the Australian Regenerative Medicine Institute (ARMI) have formed a research collaboration to advance a novel natural killer cell-derived extracellular vesicle (NK-EV) therapy ...

Cancer remains one of the hardest diseases to treat because cancer cells can grow quickly, spread through the body, and ...